INTEGRA's $10,000 cancer centre donation
Laboratory tool provider INTEGRA Biosciences — which earlier this year released a limited edition PIPETGIRL pink pipette controller in support of breast cancer research — has made a $10,000 contribution to the Susan F Smith Center for Women’s Cancers at the Dana-Farber Cancer Institute in Boston, USA.
At the beginning of 2015, INTEGRA decided to donate $15 for every purchase of PIPETGIRL to research institutes dedicated to finding a cure for breast cancer. The pipette controller is said to combine all the essential characteristics for productive work with serological pipettes — precision, speed, ease of use, lightweight operating comfort and long battery life.
The company also visited the Susan F Smith Center, which unites many of the world’s leading experts in breast and gynaecologic cancers with one common goal: to give all women the latest, most advanced care, including therapies that are often available only through clinical trials. Marc Hamel, INTEGRA’s director of US Sales, said the company “learned so much about the incredible work being undertaken at this prestigious patient treatment facility specifically in the area of breast cancer”.
“Empowered by the laboratory community’s enthusiastic response to our PIPETGIRL pipette controller, I am delighted that we have reached our first milestone — a $10,000 contribution to Dana-Farber,” Hamel said.
Dr Chris Baldwin is new HaemaLogiX CEO and Managing Director
Having commenced in January, Dr Chris Baldwin is clinical stage Australian biotechnology company...
Vaxxas appoints former Merck Global Vaccines President David Peacock as CEO
To lead the commercialisation of Vaxxas's proprietary high‑density microarray patch (HD‑MAP)...
Optics11 Life appoints Jacquelien ten Dam as CEO
Optics11 Life plans to accelerate its commercial growth in key markets while building strategic...
